Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

PRAETORIAN · EuroPean Training NetwoRks to TArget DAMPs and NETs: novel apprOaches in pRecision SepsIs pAtieNt care

HORIZONStatus: SIGNED1 January 202431 December 2027EU funding €2,726,568Call HORIZON-MSCA-2022-DN-01

Sepsis remains one of the major challenges for societies worldwide, causing an estimated 7-9 million deaths every year. It is the leading cause of death at intensive care units in the EU. This high mortality persists because at present methods for timely diagnosis are lacking and no effective therapy is available. Therefore, there is a clear and urgent medical need to provide novel diagnostics and therapeutics for use in sepsis. The PRAETORIAN Doctoral Network has created a doctorate programme to deliver innovative training on preclinical and clinical science, business- and entrepreneurial aspects, intellectual properties and more, covering multiple aspects of the drug discovery and development process. This programme is unique as it will deliver a new generation of young scientists, each Doctoral Candidates (DCs), who will collaboratively work to develop novel approaches in precision sepsis patient care providing new diagnostics and therapeutics to answer to an urgent unmet clinical need. Recent insights have indicated a pivotal role for neutrophil activation and so-called damage associated patterns in the initiation and propagation of sepsis. However a comprehensive view on how these processes cause the onset of sepsis remains elusive and there is an urgent need to translate experimental findings into adequate diagnostic and therapeutic solutions. PRAETORIAN was designed to address this urgent need by bringing together specialists from academia and industry to shape a new generation of entrepreneurial scientists who have skills, expertise and knowhow to further our understanding of sepsis pathophysiology into tangible and effective solutions for novel diagnosis and therapy.

Consortium · 18 organisations

coordinator

UNIVERSITEIT MAASTRICHT

NL · €548,741

associatedPartner

BerGenBio AS

NO

associatedPartner

Sepsisföreningen

SE

participant

UNIVERSITAET MUENSTER

DE · €521,078

associatedPartner

BIOSYNTH BV

NL

associatedPartner

5-Diagnostics Ltd

CH

associatedPartner

Double Green Pharma

NL

participant

UPPSALA UNIVERSITET

SE · €587,419

participant

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS

ES · €503,942

associatedPartner

HOPITAL ERASME - CLINIQUES UNIVERSITAIRES DE BRUXELLES

BE

associatedPartner

FRANCE SEPSIS ASSOCIATION

FR

associatedPartner

MAASTRICHT HEALTH CAMPUS BV

NL

associatedPartner

NSBM

NL

participant

UNIVERSITE PARIS CITE

FR · €565,387

associatedPartner

Deutsche Sepsis-Gesellschaft e.V.

DE

associatedPartner

PHARMATARGET BV

NL

associatedPartner

Stichting Family and patient Centered Intensive Care (FCIC)

NL

associatedPartner

Basic Pharma Technologies B.V.

NL

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.